Extracorporeal Pulse Activation Therapy and Amniotic Extracellular Matrix Injection for post-traumatic subtalar joint osteoarthritis: A case study
AuthorLabbad, Ziad G.
SubjectExtracorporeal Pulse Activation Therapy
Amniotic Extracellular Matrix
Permanent link to this recordhttp://hdl.handle.net/20.500.12613/9052
MetadataShow full item record
AbstractThis case study evaluates the use of Extracorporeal Pulse Activation Therapy (EPAT) and Amniotic Extracellular Matrix Injection (AEMI) in a patient suffering unilateral post-traumatic subtalar joint (STJ) osteoarthritis. Following an injury he was not able to work or exercise secondary to subtalar joint pain. He had failed treatment with bracing, physical therapy, and PRP injections and was not interested in surgery. Following serial EPAT and AEMI the patient had a decrease in pain score (from 5/10 at rest, to 2/10 with activity and 0/10 at rest) and was able to return to work and activities. In conclusion, EPAT and AEMI are effective treatments for STJ arthritis, present a viable alternative to surgery, and should be explored for use in other degenerative conditions of the foot and ankle.
CitationLabbad Z, Love E, Shulmister J, Adduru R. Extracorporeal Pulse Activation Therapy and Amniotic Extracellular Matrix Injection for post-traumatic subtalar joint osteoarthritis: A case study. The Journal of the International Foot & Ankle Foundation [Internet]. 2022 Mar 8;1(3). Available from: https://internationalfootankle.org/journal/index.php/JIFAF/article/view/11 doi: 10.55067/jifaf.v1i3.11
Citation to related workInternational Foot & Ankle Foundation
Has partThe Journal of the International Foot & Ankle Foundation, Vol. 1, No. 3
ADA complianceFor Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact firstname.lastname@example.org
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs CC BY-NC-ND